Therefore, we compared the admission (pretreatment) plasma levels of C1q, C2, C4, C4b, MBL, C5, C5a, C3, C3b, factor B, factor D, factor H, and factor I between children with COVID-19 who developed moderate or severe disease and those who developed only mild disease. This evidence concerns the gene C4A and COVID-19.